These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20884060)

  • 1. Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases.
    Khan YA; Kashiwabuchi RT; Martins SA; Castro-Combs JM; Kalyani S; Stanley P; Flikier D; Behrens A
    Ophthalmology; 2011 Feb; 118(2):324-31. PubMed ID: 20884060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Riboflavin/UVA photochemical therapy for severe infectious keratitis.
    Skaat A; Zadok D; Goldich Y; Varssano D; Berger Y; Ezra-Nimni O; Avni I; Barequet IS
    Eur J Ophthalmol; 2014; 24(1):21-8. PubMed ID: 23873492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymicrobial keratitis: Acanthamoeba and infectious crystalline keratopathy.
    Tu EY; Joslin CE; Nijm LM; Feder RS; Jain S; Shoff ME
    Am J Ophthalmol; 2009 Jul; 148(1):13-9.e2. PubMed ID: 19327742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis.
    Robaei D; Carnt N; Minassian DC; Dart JK
    Ophthalmology; 2014 Jul; 121(7):1383-8. PubMed ID: 24630688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acanthamoeba keratitis].
    Bouheraoua N; Labbé A; Chaumeil C; Liang Q; Laroche L; Borderie V
    J Fr Ophtalmol; 2014 Oct; 37(8):640-52. PubMed ID: 25169145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photo-activated riboflavin therapy of refractory corneal ulcers.
    Panda A; Krishna SN; Kumar S
    Cornea; 2012 Oct; 31(10):1210-3. PubMed ID: 22710492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful medical treatment of Acanthamoeba keratitis.
    Azuara-Blanco A; Sadiq AS; Hussain M; Lloyd JH; Dua HS
    Int Ophthalmol; 1997-1998; 21(4):223-7. PubMed ID: 9700010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors affecting visual outcome in Acanthamoeba keratitis.
    Tu EY; Joslin CE; Sugar J; Shoff ME; Booton GC
    Ophthalmology; 2008 Nov; 115(11):1998-2003. PubMed ID: 18571729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acanthamoeba keratitis due to genotype T11 in a rigid gas permeable contact lens wearer in Spain.
    Lorenzo-Morales J; Morcillo-Laiz R; Martín-Navarro CM; López-Vélez R; López-Arencibia A; Arnalich-Montiel F; Maciver SK; Valladares B; Martínez-Carretero E
    Cont Lens Anterior Eye; 2011 Apr; 34(2):83-6. PubMed ID: 21130679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors associated with the need for surgical treatments in acanthamoeba keratitis.
    Bouheraoua N; Gaujoux T; Goldschmidt P; Chaumeil C; Laroche L; Borderie VM
    Cornea; 2013 Feb; 32(2):130-6. PubMed ID: 23132441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine.
    Seal D; Hay J; Kirkness C; Morrell A; Booth A; Tullo A; Ridgway A; Armstrong M
    Eye (Lond); 1996; 10 ( Pt 4)():413-21. PubMed ID: 8944089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis.
    Bang S; Edell E; Eghrari AO; Gottsch JD
    Am J Ophthalmol; 2010 Jan; 149(1):66-9. PubMed ID: 19875089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Painless Acanthamoeba Keratitis with Normal Vision.
    Kwok PW; Kam KW; Jhanji V; Young AL
    Optom Vis Sci; 2017 Mar; 94(3):432-435. PubMed ID: 27870779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of infectious keratitis with riboflavin and ultraviolet-A irradiation.
    Chan E; Snibson GR; Sullivan L
    J Cataract Refract Surg; 2014 Nov; 40(11):1919-25. PubMed ID: 25262564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal cross-linking for Acanthamoeba keratitis in an orthokeratology patient after swimming in contaminated water.
    Arance-Gil Á; Gutiérrez-Ortega ÁR; Villa-Collar C; Nieto-Bona A; Lopes-Ferreira D; González-Méijome JM
    Cont Lens Anterior Eye; 2014 Jun; 37(3):224-7. PubMed ID: 24355444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of in vitro efficacy of combined riboflavin and ultraviolet a for Acanthamoeba isolates.
    del Buey MA; Cristóbal JA; Casas P; Goñi P; Clavel A; Mínguez E; Lanchares E; García A; Calvo B
    Am J Ophthalmol; 2012 Mar; 153(3):399-404. PubMed ID: 21992713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.
    Pérez-Santonja JJ; Kilvington S; Hughes R; Tufail A; Matheson M; Dart JK
    Ophthalmology; 2003 Aug; 110(8):1593-600. PubMed ID: 12917179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology.
    Price MO; Tenkman LR; Schrier A; Fairchild KM; Trokel SL; Price FW
    J Refract Surg; 2012 Oct; 28(10):706-13. PubMed ID: 23062001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acanthamoeba keratitis: persistent organisms without inflammation after 1 year of topical chlorhexidine.
    Gooi P; Lee-Wing M; Brownstein S; El-Defrawy S; Jackson WB; Mintsioulis G
    Cornea; 2008 Feb; 27(2):246-8. PubMed ID: 18216589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultraviolet A and riboflavin therapy as an adjunct in corneal ulcer refractory to medical treatment.
    Sağlk A; Uçakhan OO; Kanpolat A
    Eye Contact Lens; 2013 Nov; 39(6):413-5. PubMed ID: 24172067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.